BIOMIND LABS INC. (3XI) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
BIOMIND LABS INC. (3XI) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €19.66K. See net asset quality index of BIOMIND LABS INC. to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
€0.00
Capex + Investments
Operating Cash Flow
€19.66K
EUR
Capital Expenditures
€0.00
EUR
Annual Cash Flow Reinvestment Rate for BIOMIND LABS INC. (None–None)
Year-by-year capital reinvestment analysis for BIOMIND LABS INC.. For live market cap and broader valuation context, see 3XI stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow